CCSD code S0982 – Localised phototherapy billing guide

Key Takeaways

CCSD Code S0982 covers localised phototherapy (UVB/PUVA/PUVB) billed per individual treatment session, not per course.

Three modalities are billable under S0982: narrowband or broadband UVB, PUVA (psoralen plus UVA), and PUVB (psoralen plus UVB).

The correct ICD-10 diagnosis code must accompany every S0982 claim; missing or mismatched diagnosis codes are a leading cause of repudiation.

Pabau’s dermatology practice management software tracks cumulative session counts, links ICD-10 codes at claim level, and generates audit-ready session records for S0982 billing.

CCSD Code S0982: Definition and clinical description

CCSD Code S0982 is the official South African CCSD tariff code for phototherapy (UVB/PUVA/PUVB) per session, localised. The Coding Committee on Surgical Disciplines (CCSD) publishes this code in its annual code book. The descriptor is precise on two counts. First, the treatment must be localised, meaning it targets a defined anatomical site rather than the whole body. Second, each session generates a separate claim line.

Localised, in the context of this code, means the ultraviolet source treats a partial body area rather than the full body surface. A hand-and-foot cabinet, a targeted excimer lamp, or a small-panel UVB unit treating one anatomical region all qualify. In contrast, full-body phototherapy, where the patient steps into a stand-up cabinet that exposes the entire skin surface, falls under a different CCSD code.

What S0982 covers: UVB, PUVA, and PUVB explained

Three distinct phototherapy modalities fall under the S0982 billing descriptor. Each involves different light sources, sensitisers, and clinical set-ups. However, all three are billable per localised session under this single code.

• UVB (ultraviolet B): The most commonly administered modality. Narrowband UVB (NB-UVB, peak emission 311 nm) is first-line for psoriasis and vitiligo in most South African dermatology practices. Broadband UVB covers a wider spectrum, and older equipment still uses it. Therefore, neither type needs a photosensitising agent.
• PUVA (psoralen plus UVA): Requires the patient to ingest or apply a psoralen photosensitiser before exposure to UVA light. Patients take oral psoralen (8-methoxypsoralen, 8-MOP) 1 to 2 hours before the session, while staff apply topical psoralen directly to the treatment area. Clinicians use PUVA for palmoplantar psoriasis, lichen planus, and selected other photoresponsive conditions.
• PUVB (psoralen plus UVB): Combines psoralen sensitisation with UVB rather than UVA. Less commonly used than PUVA or standalone NB-UVB, but explicitly included in the S0982 descriptor and therefore billable under this code for localised application.

Whether the psoralen drug itself is included in the S0982 tariff or billed as a separate dispensed item depends on the scheme’s formulary rules. The psoralen billing section below covers this in more detail.

Clinical indications: When is S0982 correctly billed?

S0982 is correctly billed when localised phototherapy is clinically indicated and the treating dermatologist has documented a diagnosis that medical schemes recognise as a covered phototherapy indication. The table below pairs the most widely accepted diagnoses with their ICD-10 codes.

ICD-10 codes to submit with S0982

Every S0982 claim requires a valid ICD-10 diagnosis code. The WHO ICD-10 browser provides authoritative definitions for each of these codes. In addition, the table below maps the most common phototherapy indications to their codes.

Use the most specific ICD-10 code available. For example, submitting L30.9 when L40.0 is clinically correct is a common audit flag. Also, confirm acceptable codes per each scheme’s current benefit rules, because coverage criteria for atopic eczema and parapsoriasis can vary between benefit options.

S0982 vs S0983: Localised vs generalised phototherapy

The distinction between S0982 and S0983 turns entirely on the extent of skin surface irradiated during the session. S0982 applies to localised phototherapy, where the clinician targets a defined anatomical region. In contrast, S0983 applies to generalised (whole-body) phototherapy, where light reaches the full or near-full body surface, typically in a walk-in UV cabinet.

Miscoding between the two is a frequent billing error. For example, using S0983 for a hand-and-foot unit session, or submitting S0982 for a full-body cabinet session, constitutes incorrect coding and can result in claim rejection or retrospective audit liability.

When a patient transitions from localised to generalised treatment as their disease progresses, update the billing code accordingly and document the clinical rationale for the change in the treatment record.

Related and adjacent CCSD codes to know

S0982 does not operate in isolation. Dermatology billers therefore need to know which adjacent codes may appear on the same claim and which create unbundling risk.

Billing a consultation code on a phototherapy-only visit is an unbundling error. Also, the session note must show whether the dermatologist conducted a consultation separately. Pabau’s claims management software flags potential unbundling conflicts before submission, reducing audit exposure for South African dermatology practices. For a broader overview of CCSD billing in private healthcare, the CCSD billing guide covers code structure and submission rules applicable across the private system.

Documentation requirements for billing S0982

Per-session documentation is non-negotiable for S0982 claims. Medical schemes audit phototherapy courses because the per-session billing model creates a high-volume, repetitive claim pattern. As a result, every attendance needs its own clinical record made at the time of treatment.

Pabau’s structured treatment records allow phototherapy teams to log each session with the required clinical fields built into the form, so no detail slips between the treatment room and the claim.

Each session record must include:

• Date of treatment
• Modality administered (UVB, PUVA, or PUVB – specify narrowband vs broadband for UVB)
• Anatomical areas treated (must be consistent with the localised code, not whole-body)
• Dose delivered (joules per cm²)
• Cumulative dose to date (total joules/cm² across the treatment course)
• Patient response (erythema, tolerability, clinical response to date)
• Next planned dose (dose increment plan or reason for no increment)
• Psoralen administration details (for PUVA/PUVB: Route, dose, time before exposure)

Minimal erythema dose (MED) testing is standard clinical practice before starting UVB phototherapy. Therefore, document the MED determination in the patient record at the start of each course. Some schemes may request this record during audit, though requirements vary.

Pre-authorisation requirements for phototherapy

Most major South African medical schemes require prior authorisation before funding a phototherapy course billed under S0982, though the exact requirement varies by scheme and benefit option. Therefore, the practice should confirm the pre-auth status for each patient’s specific medical scheme plan before the first session.

Typical pre-authorisation criteria across schemes include:

• Diagnosis confirmed by a registered dermatologist (HPCSA-registered specialist)
• Evidence of failed or inadequate response to topical therapy
• ICD-10 diagnosis code submitted with the motivation
• Proposed number of sessions and treatment schedule
• Equipment type and modality (localised vs generalised, UVB vs PUVA)

Session limits and frequency rules

Schemes typically authorise phototherapy in treatment courses rather than open-ended, and session limits vary between plans. Because scheme rules change annually under the Medical Schemes Act 131 of 1998, never apply a universal session cap without confirming the current benefit year’s rules with the specific scheme.

When a patient’s condition requires sessions beyond the authorised number, submit a clinical motivation before the patient reaches the authorised limit. Include cumulative dose records, clinical progress notes, and the treating dermatologist’s assessment. However, if you submit the motivation after exceeding the limit, the scheme almost always rejects the excess sessions after the fact.

Billing S0982 correctly in practice management software

CCSD Code S0982 generates a claim line for every session. For example, for a patient attending three times a week across a 30-session course, that is 30 individual claim submissions, each requiring the correct ICD-10 code, a session-specific clinical note, and a session count that the practice can demonstrate has not exceeded the authorised limit.

Fortunately, practices using dermatology practice management software built for the South African private billing environment can automate much of this. The key workflow steps are:

1. Set up S0982 as a recurring treatment line item linked to the patient’s authorisation number and ICD-10 diagnosis code at the account level, so both populate automatically on each session invoice.
2. Build the phototherapy session note template with mandatory fields (modality, anatomical site, dose, cumulative dose, patient response, next dose plan) so practitioners cannot submit the form without completing them.
3. Track cumulative sessions against the authorised session count using an alert or counter visible to the treating team, flagging when the practice approaches the scheme’s authorised limit.
4. Generate the claim with the correct code, ICD-10, authorisation number, and session-specific clinical note attached before submission.
5. Record and reconcile payments per session against the tariff rate applicable for the current year, noting any scheme-specific rate differences.

Pabau’s clinic software for South African practices supports CCSD-structured billing workflows, links ICD-10 codes at the claim level, and maintains the per-session documentation trail that medical scheme auditors expect.

Manage CCSD phototherapy billing without the admin overhead

Pabau tracks every S0982 session, links ICD-10 codes automatically, and flags when cumulative sessions approach authorisation limits, so your dermatology practice bills cleanly and audits confidently.

Book a demo

Psoralen administration and its billing implications

PUVA and PUVB sessions require psoralen, a photosensitising agent that patients take orally (8-methoxypsoralen, typically 0.6 mg/kg body weight, 1 to 2 hours before UVA exposure) or apply topically (directly to the treatment area 15 to 30 minutes before irradiation). Whether the psoralen drug is included in the S0982 tariff or requires a separate billing line depends on the scheme.

The key billing questions to resolve with each scheme before starting a PUVA or PUVB course:

• Is the psoralen agent included within the S0982 tariff, or must it be billed separately as a dispensed item?
• If separately billed, does the psoralen require its own pre-authorisation line?
• For topical psoralen applied by the practice, is a nursing or treatment-room dispensing code applicable?
• For oral psoralen prescribed for self-administration, is it a scheme-formulary item or an over-the-counter purchase?

Document the psoralen route, dose, batch number, and timing in the session note regardless of how you bill it. Moreover, this information supports safety monitoring (cumulative psoralen exposure, ocular protection compliance) and helps you respond to scheme queries about PUVA or PUVB claims.

Common claim denial reasons for S0982 and how to avoid them

Schemes deny S0982 claims for a small set of common reasons. Fortunately, the documentation and pre-authorisation steps described above prevent most of them.

Conclusion

Localised phototherapy billing under S0982 is straightforward when the per-session documentation, ICD-10 pairing, and pre-authorisation steps are built into the practice workflow from the start. In practice, the two most preventable claim failures are missing ICD-10 codes and sessions that exceed the authorised count.

Pabau’s dermatology billing tools track cumulative session counts against authorisation limits, enforce mandatory session note fields, and link ICD-10 codes at the claim level, so your team spends less time fixing denied claims and more time treating patients. Book a demo to see how Pabau handles CCSD phototherapy billing end to end.

Continue your research

Need a broader CCSD billing reference? Bupa CCSD codes guide covers CCSD code structure and private insurer submission rules in depth.

Want to reduce claim denials across the full practice? Claims management software from Pabau flags coding conflicts and tracks claim status from submission to payment.

Building out your dermatology practice operations? Dermatology practice management software from Pabau covers scheduling, clinical records, and CCSD-structured billing in one system.

Frequently Asked Questions